Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014;38(3):661-8.
doi: 10.3233/JAD-131142.

A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients

Affiliations
Multicenter Study

A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients

Qolamreza R Razlighi et al. J Alzheimers Dis. 2014.

Abstract

Background: The ability to predict the length of time to death and institutionalization has strong implications for Alzheimer's disease patients and caregivers, health policy, economics, and the design of intervention studies.

Objective: To develop and validate a prediction algorithm that uses data from a single visit to estimate time to important disease endpoints for individual Alzheimer's disease patients.

Method: Two separate study cohorts (Predictors 1, N = 252; Predictors 2, N = 254), all initially with mild Alzheimer's disease, were followed for 10 years at three research centers with semiannual assessments that included cognition, functional capacity, and medical, psychiatric, and neurologic information. The prediction algorithm was based on a longitudinal Grade of Membership model developed using the complete series of semiannually-collected Predictors 1 data. The algorithm was validated on the Predictors 2 data using data only from the initial assessment to predict separate survival curves for three outcomes.

Results: For each of the three outcome measures, the predicted survival curves fell well within the 95% confidence intervals of the observed survival curves. Patients were also divided into quintiles for each endpoint to assess the calibration of the algorithm for extreme patient profiles. In all cases, the actual and predicted survival curves were statistically equivalent. Predictive accuracy was maintained even when key baseline variables were excluded, demonstrating the high resilience of the algorithm to missing data.

Conclusion: The new prediction algorithm accurately predicts time to death, institutionalization, and need for full-time care in individual Alzheimer's disease patients; it can be readily adapted to predict other important disease endpoints. The algorithm will serve an unmet clinical, research, and public health need.

Keywords: Alzheimer's disease; full-time care; grade of membership model; nursing home; prediction algorithm; time to death.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any conflict of interest.

Figures

Figure 1
Figure 1
A representation of the longitudinal GoM model. See text for explanation. PT= pure type.
Figure 2
Figure 2
Comparison of the predicted and observed survival curve a) for all subject, b) for male subjects, c) for female subjects, and d) ~ h) for five quintiles ordered by predicted life expectancy.
Figure 3
Figure 3
Comparison of the predicted and observed survival curve for entering nursing home a) for all subjects, b) for male subjects, c) for female subjects, and d) ~ h) for five quintiles ordered by predicted time to nursing home admission.
Figure 4
Figure 4
Comparison of the predicted and observed survival curve for need for full-time care a) for all subjects, b) for male subjects, c) for female subjects, and d) ~ h) for five quintiles ordered by predicted time to need for full time care.

References

    1. Stallard E, Kinosian B, Zbrozek AS, Yashin AI, Glick Ha, Stern Y. Estimation and validation of a multiattribute model of Alzheimer disease progression. Medical decision making : an international journal of the Society for Medical Decision Making. 2010;30:625–638. - PMC - PubMed
    1. Neumann PJ, Araki SS, Arcelus A, Longo A, Papadopoulos G, Kosik KS, Kuntz KM, Bhattacharjya A. Measuring Alzheimer’s disease progression with transition probabilities: estimates from CERAD. Neurology. 2001;57:957–964. - PubMed
    1. Green C. Modelling disease progression in Alzheimer’s disease: a review of modelling methods used for cost-effectiveness analysis. PharmacoEconomics. 2007;25:735–750. - PubMed
    1. Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai WY. Application of a growth curve approach to modeling the progression of Alzheimer’s disease. The journals of gerontology Series A Biological sciences and medical sciences. 1996;51:M179–M184. - PubMed
    1. Eisdorfer C, Cohen D, Paveza GJ, Ashford JW, Luchins DJ, Gorelick PB, Hirschman RS, Freels SA, Levy PS, Semla TP. Empirical evaluation of the global deterioration scale for staging Alzheimer’s disease. The American journal of psychiatry. 1993;150:190–194. - PubMed

Publication types